A new webpage dedicated to providing useful and timely information about syringe services programs (SSPs) has just been launched, in collaboration with HIV.gov. This resource is important because the evidence is clear that the substance use crisis and infectious diseases epidemics are intertwined and must be addressed together.Read More
The Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) project is a consortium of nine cohorts studying the intersection of HIV infection and substance abuse.
COVID-19: C3PNO Cohort PIs
You can locate additional documents on the OwnCloud file sharing space
What is C3PNO?
The Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) is the coordinating center for the National Institute on Drug Abuse (NIDA) U01 cohorts. C3PNO manages and stimulates the use of the NIDA longitudinal cohorts and addresses high priority research on HIV/AIDS in the context of substance misuse.
C3PNO is focused on cutting-edge science powered by the cohorts’ combined sample size of approximately 12,000 participants. We have assembled a team of researchers with global leadership in HIV prevention, clinical science and co-morbidities, behavioral science, immunology, modeling, and bioethics to work with NIDA program scientists to align and stimulate the highest impact science across NIDA-funded cohorts that have compiled unique repositories of varied and rich data.
Submit a Concept to Request C3PNO Data
Researchers may request to use data collected by the C3PNO cohorts. You can search for available data on the Virtual Data Repository and then submit a concept to formally request data and specimens.
Across the country, HIV service organizations and providers are working with people with HIV to support adherence to antiretroviral medications during the COVID-19 pandemic and to maintain ongoing access to HIV testing, prevention, and care services. HIV.gov has curated a collection of key federal resources related to HIV and COVID-19 to assist in this effort. Information is regularly being updated as we learn more in this evolving situation.Read More
Questions about Specimens or Data?
Contact Us for assistance.